DocMode Health Technologies
- Market cap
- ₹ 7 Cr.
- P/E
- 171.9x
- P/B
- 0.85x
- 52-week range
- 21.9 – 125.2
- ROE
- −2%
- ROCE
- 6.1%
- Dividend yield
- 0%
- Debt / equity
- 0.45
- Sector
- Other Consumer Services
- Industry
- E-Learning
- Listed on
- NSE SME
About
DocMode Health Technologies Ltd is an India-based company. The Company is engaged in the business of offering integrated learning solutions through online and offline learning model to health care professionals and learners across the world, spanning the education value chain. The Company's offline learning model includes conferences and workshops, while the online courses are developed and presented by the in-house content development team, medical institutions, associations, subject matter experts, and key opinion leaders. It is engaged in the business of providing vocational training. Its DocMode is a platform that provides authoritative, comprehensive, and interactive learning programs for health professionals, doctors, nurses, allied and medical students across the world. Its product caters to the diverse needs of healthcare professionals, spanning across its ecosystem, such as learning, practice, research, and patients.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
E-Learning: 10 companies →DocMode Health Technologies against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)171.9 against a typical 80.9: pricier than most peers (1st = cheapest).7th of 9
- Sales growth−53.2% against a typical −7.7% from a year earlier.7th of 7
- Share price, 3 months−38.1% against a typical +1.1%.8th of 8
- Size₹ 6.9 Cr. market value against a typical ₹ 70.4 Cr. (1st = largest).8th of 8
Latest announcements
Exchange filings and their impact on the company.
- FY26 results reveal 39% revenue collapse and auditor-flagged Rs 2.25 cr NCD default with promoter shares invoked.
Doctrack Solutions reported audited FY26 consolidated revenue of Rs 25.52 crore, down 39% from Rs 41.77 crore, with a net loss of Rs 0.13 crore versus Rs 2.03 crore last year. The auditor issued a qualified opinion because the company defaulted on Rs 2.25 crore of 18-18.5% NCDs due by November 2025 and did not provide Rs 0.30 crore of coupon and default interest. Following the default, lenders invoked 5.65 lakh pledged promoter shares in August-November 2025, adding balance-sheet and governance stress.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 4 Sep 2026 | Financial Results | To consider and approve Audited Standalone and Consolidated Financial Results for the half year and financial year ended on 31st March, 2026. |
| 30 May 2026 | Financial Results | To consider and approve Audited Standalone and Consolidated Financial Results for the half year and financial year ended on 31st March, 2026. |
| 3 Dec 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 24 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 14 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 30 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 20 | 24 | 16 | 20 | 21 | 18 | 8 |
| Expenses | 19 | 21 | 17 | 21 | 22 | 17 | 9 |
| Operating Profit | 1 | 3 | −1 | −0 | −1 | 1 | −1 |
| OPM % | 7.2% | 11.5% | −5.1% | −0.6% | −2.9% | 4.5% | −15.1% |
| Other Income | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | −2 | −1 | −2 | −0 | −0 |
| Tax % | 18.4% | 29.2% | −25.8% | 2% | 4% | 0% | 0% |
| Net Profit | 1 | 1 | −1 | −1 | −2 | −0 | −0 |
| EPS in Rs | 2.66 | 5.93 | −3.72 | −1.65 | −5.03 | −0.29 | −0.22 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 29%
- 3 Years
- −8%
- TTM
- −39%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 94%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 3%
- 3 Years
- −8%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| DocMode Health Technologies | ₹ 22.05 | ₹ 7 Cr. | 171.9x | 0.9x | −2% | — |
| Swiggy | ₹ 176.00 | ₹ 48,582 Cr. | — | 4x | — | −15.1% |
| Delhivery | ₹ 370.00 | ₹ 27,724 Cr. | 204.2x | 3.4x | — | 0.8% |
| Urban Company | ₹ 132.75 | ₹ 20,472 Cr. | — | 11.5x | — | −19.5% |
| Sagility | ₹ 44.18 | ₹ 20,682 Cr. | 21.3x | 2.1x | — | 13% |
| Indegene | ₹ 571.90 | ₹ 13,809 Cr. | 32.8x | 4.4x | — | 10.5% |
Management
- Hans Albert Lewis
- Chief Financial Officer, Whole Time Director
- Paresh Jaysih Sampat
- Managing Director, Executive Director
- Paulson Paul Thazhathedath
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.